# Tonix Pharmaceuticals Holding Corp. (TNXP) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tonix Pharmaceuticals Holding Corp.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TNXP/mda/fy2025/): filed 2026-03-12; accession 0001999371-26-005730 (https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm); latest 10-K
- [FY 2024 MD&A](/company/TNXP/mda/fy2024/): filed 2025-03-18; accession 0001999371-25-002786 (https://www.sec.gov/Archives/edgar/data/1430306/000199937125002786/tnxp-10k_123124.htm)
- [FY 2023 MD&A](/company/TNXP/mda/fy2023/): filed 2024-04-01; accession 0001999371-24-004297 (https://www.sec.gov/Archives/edgar/data/1430306/000199937124004297/tnxp-10k_123123.htm)
- [FY 2022 MD&A](/company/TNXP/mda/fy2022/): filed 2023-03-13; accession 0001387131-23-003377 (https://www.sec.gov/Archives/edgar/data/1430306/000138713123003377/tnxp-10k_123122.htm)
- [FY 2021 MD&A](/company/TNXP/mda/fy2021/): filed 2022-03-14; accession 0001387131-22-003640 (https://www.sec.gov/Archives/edgar/data/1430306/000138713122003640/tnxp-10k_123121.htm)

Back to /company/TNXP/